1. Diffuse ¹⁸F-fluorodeoxyglucose uptake in the bone marrow of an elderly man with B-cell lymphoma

   • Kenki Saito
   • Kenji Notohara
   • Yasunori Ueda

   Images in Hematology 30 May 2022 Pages: 1 - 2

   

2. Unilateral recurrent laryngeal nerve palsy detected by PET/CT in a patient with mediastinal T-cell lymphoblastic lymphoma

   • Toru Miyajima
   • Yuta Hasegawa
   • Takanori Teshima

   Images in Hematology 27 May 2022 Pages: 3 - 4

   

3. Guest editorial: current status and future perspectives of allogeneic hematopoietic cell transplantation for non-malignant diseases

   • Katsutsugu Umeda

   Progress in Hematology 26 April 2022 Pages: 5 - 6

   

4. Conditioning regimens for inborn errors of immunity: current perspectives and future strategies

   • Akira Nishimura
   • Satoshi Miyamoto
   • Tomohiro Morio

   Progress in Hematology 08 June 2022 Pages: 7 - 15

   

5. Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes

   • Hirotoshi Sakaguchi
   • Nao Yoshida

   Progress in Hematology 28 May 2022 Pages: 16 - 27

   

6. Allogeneic hematopoietic stem cell transplantation for inherited metabolic disorders

   • Hiromasa Yabe

   Progress in Hematology 20 May 2022 Pages: 28 - 40

   

7. Unresolved issues in allogeneic hematopoietic cell transplantation for non-malignant diseases

   • Katsutsugu Umeda

   Progress in Hematology 14 May 2022 Pages: 41 - 47

   

8. Phenotype-oriented anticoagulant therapy for sepsis: still a work in progress

   • Sihan Yu
   • Xiaochun Ma
   • Xu Li

   Review Article 05 April 2022 Pages: 48 - 54

   

9. Hemolysis induced by SARS-CoV-2 mRNA vaccination in patients with paroxysmal nocturnal hemoglobinuria

   • Yuya Kamura
   • Tatsuhiro Sakamoto
   • Naoshi Obara

   Rapid Communication 06 June 2022 Pages: 55 - 59

   

10. Prevention of venous thromboembolism in pregnant women with congenital antithrombin deficiency: a retrospective study of a candidate protocol

    • Mamoru Morikawa
    • Masahiro Ieko
    • Hidemichi Watari

    Original Article 22 March 2022 Pages: 60 - 70

11. Companion gene mutations and their clinical significance in AML with double or single mutant CEBPA

    • JinYuan He
    • Jie Liu
    • Xiaohui Cai

    Original Article 21 March 2022 Pages: 71 - 80

    

12. Prognostic impacts of serum levels of C-reactive protein, albumin, and total cholesterol in patients with myelodysplastic syndromes

    • Hiroto Yanagisawa
    • Hiroshi Kawabata
    • Yasufumi Masaki

    Original Article 23 March 2022 Pages: 81 - 88

    

13. Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy

    • Chikashi Yoshida
    • Takeshi Kondo
    • Hitoshi Kiyoi

    Original Article 08 April 2022 Pages: 89 - 101

    

14. Characteristics and prognostic value of pleural effusion in secondary hemophagocytic lymphohistiocytosis

    • Wanying Cheng
    • Xin Gao
    • Hongxia Qiu

    Original Article 25 March 2022 Pages: 102 - 109

    

15. Characteristics and clinical outcome of high-risk multiple myeloma patients in Korea (KMM 1805)

    • Kihyun Kim
    • Jin Seok Kim
    • The Korean Multiple Myeloma Working Party (KMMWP)

    Original Article 11 May 2022 Pages: 110 - 121

    

16. Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatment

    • Kosei Matsue
    • Kazutaka Sunami
    • Shinsuke Iida

    Original Article 16 April 2022 Pages: 122 - 130

17. Ponatinib in pediatric patients with Philadelphia chromosome-positive leukemia: a retrospective survey of the Japan Children’s Cancer Group

    • Yuichi Kodama
    • Atsushi Sato
    • Hiroyuki Shimada

    Original Article 29 March 2022 Pages: 131 - 138

    

18. Chronic active Epstein–Barr virus infection presenting as refractory chronic sinusitis

    • Wataru Kitamura
    • Hideaki Fujiwara
    • Yoshinobu Maeda

    Case Report 14 February 2022 Pages: 139 - 145

    

19. Decitabine combined with minimally myelosuppressive therapy for induction of remission in pediatric high-risk acute myeloid leukemia with chromosome 5q deletion: a report of three cases

    • Shengqin Cheng
    • Peifang Xiao
    • Shaoyan Hu

    Case Report 18 February 2022 Pages: 146 - 151

20. Lupus anticoagulant-hypoproaccelerin (factor V) syndrome (LAHPS-V): a new hemorrhagic condition associated with lupus anticoagulant

    • Masahiro Ieko
    • Sumiyoshi Naito
    • Akitada Ichinose

    Letter to the Editor 24 May 2022 Pages: 152 - 154